CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7%

MT Newswires Live

2024-09-13

CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7%

CellSource (TYO:4880) will offer an updated extraction technology in October for adipose-derived cultured stem cells, which could improve the removal of senescent cells and enhance overall cell quality.

The updated extraction technology was inspired by the development of extracellular vesicle manufacturing technology, according to its Thursday filing.

The development reflects ongoing efforts to update services based on insights from cell and blood processing research and collaborations.

CellSource's shares lost over 7% in early trade.

Price (JPY): $1283.00, Change: $-98, Percent Change: -7.10%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2467750112"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2467750112\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2467750112?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-13 09:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467750112","market":"nz","top_or_hot":-1,"title":"CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7%","media":"MT Newswires Live","content":"<html><body><p>CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7%</p><p> CellSource (TYO:4880) will offer an updated extraction technology in October for adipose-derived cultured stem cells, which could improve the removal of senescent cells and enhance overall cell quality.</p><p>The updated extraction technology was inspired by the development of extracellular vesicle manufacturing technology, according to its Thursday filing.</p><p>The development reflects ongoing efforts to update services based on insights from cell and blood processing research and collaborations.</p><p>CellSource's shares lost over 7% in early trade.</p><p>Price (JPY): $1283.00, Change: $-98, Percent Change: -7.10%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7%\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MT Newswires Live</strong><span class=\"h-time small\">2024-09-13 09:08</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p>CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7%</p><p> CellSource (TYO:4880) will offer an updated extraction technology in October for adipose-derived cultured stem cells, which could improve the removal of senescent cells and enhance overall cell quality.</p><p>The updated extraction technology was inspired by the development of extracellular vesicle manufacturing technology, according to its Thursday filing.</p><p>The development reflects ongoing efforts to update services based on insights from cell and blood processing research and collaborations.</p><p>CellSource's shares lost over 7% in early trade.</p><p>Price (JPY): $1283.00, Change: $-98, Percent Change: -7.10%</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.mtnewswires.com/\">MT Newswires Live</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TYO","symbol_name":"3倍做空7-10年期國債ETF-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2467750112","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467750112","pubTimestamp":1726189713,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7% CellSo","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TYO":"3倍做空7-10年期国债ETF-Direxion"},"translate_title":"CellSource将推出增强型脂肪干细胞提取技术；股价下跌7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TYO":1},"content_text":"CellSource to Launch Enhanced Adipose-Derived Stem Cell Extraction Technology; Shares Down 7% CellSource (TYO:4880) will offer an updated extraction technology in October for adipose-derived cultured stem cells, which could improve the removal of senescent cells and enhance overall cell quality.The updated extraction technology was inspired by the development of extracellular vesicle manufacturing technology, according to its Thursday filing.The development reflects ongoing efforts to update services based on insights from cell and blood processing research and collaborations.CellSource's shares lost over 7% in early trade.Price (JPY): $1283.00, Change: $-98, Percent Change: -7.10%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}